Device and Method to Treat Fertility Using In-Vivo Micro-Organs

Mitrani Eduardo, HUJI, Faculty of Science, The Alexander Silberman Institute for Life Sciences
Revel Ariel




Fertility, medical device


Development Stage:


Preliminary POC with supporting in-vivo data


Our Innovation

Simple disposable patented device for infertility treatment  


The device can be operated through a standard trocar during ovarian laparoscopy surgery, and achieves its fertility-enhancing-activity via simple mechanical manipulation

The Opportunity

One out of every eight couples are affected by infertility. According to the American Society for Reproductive Medicine (ASRM), the inability to have a child affects around 6.7 million women in the U.S, which accounts for around 11.0% of the reproductive population. Moreover, 25% of the couples have more than one factors leading to infertility. As people live longer, and more women decide to develop a career before raising children, the clinical need and market opportunity of alternative methods to increase fertility in women is expected to grow significantly in the next few years.




Contact for more information:

Mel Larrosa
VP Business Development Healthcare